Search research articles
Contact Us
Filters
Showing results (931-940 of 989) with videos related to
Page
of 99
Sort By:
Cell Metabolism
|
December 2, 2025
Digital twins for in vivo metabolic flux estimations in patients with brain cancer
Baharan Meghdadi, Wajd N Al-Holou, Andrew J Scott, et al.
Neuro-Oncology
|
December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop
Jason T Huse, Max Wallace, Kenneth D Aldape, et al.
Plos One
|
April 10, 2009
Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone
Khalid S Mohammad, Carol G Chen, Guive Balooch, et al.
Journal of Neuropathology and Experimental Neurology
|
September 22, 2018
A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma
Jennifer W Koehler, Andrew D Miller, C Ryan Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2013
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class
W Caleb Rutledge, Jun Kong, Jingjing Gao, et al.
Schizophrenia Bulletin
|
July 19, 2020
A White Matter Connection of Schizophrenia and Alzheimer's Disease
Peter Kochunov, Artemis Zavaliangos-Petropulu, Neda Jahanshad, et al.
Nature Communications
|
March 4, 2024
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma
Xing Cheng, Jing An, Jitong Lou, et al.
Human Brain Mapping
|
May 29, 2020
Translating ENIGMA schizophrenia findings using the regional vulnerability index: Association with cognition, symptoms, and disease trajectory
Peter Kochunov, Fengmei Fan, Meghann C Ryan, et al.
JCI Insight
|
July 19, 2022
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
Hasibur Rehman, Darshan S Chandrashekar, Chakravarthi Balabhadrapatruni, et al.
Blood
|
June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Page
of 99
Search research articles
Search
Showing results (931-940 of 989) with videos related to
Sort By:
Page
of 99
Cell Metabolism
|
December 2, 2025
Digital twins for in vivo metabolic flux estimations in patients with brain cancer
Baharan Meghdadi, Wajd N Al-Holou, Andrew J Scott, et al.
Neuro-Oncology
|
December 6, 2013
Where are we now? And where are we going? A report from the Accelerate Brain Cancer Cure (ABC2) low-grade glioma research workshop
Jason T Huse, Max Wallace, Kenneth D Aldape, et al.
Plos One
|
April 10, 2009
Pharmacologic inhibition of the TGF-beta type I receptor kinase has anabolic and anti-catabolic effects on bone
Khalid S Mohammad, Carol G Chen, Guive Balooch, et al.
Journal of Neuropathology and Experimental Neurology
|
September 22, 2018
A Revised Diagnostic Classification of Canine Glioma: Towards Validation of the Canine Glioma Patient as a Naturally Occurring Preclinical Model for Human Glioma
Jennifer W Koehler, Andrew D Miller, C Ryan Miller, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 19, 2013
Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class
W Caleb Rutledge, Jun Kong, Jingjing Gao, et al.
Schizophrenia Bulletin
|
July 19, 2020
A White Matter Connection of Schizophrenia and Alzheimer's Disease
Peter Kochunov, Artemis Zavaliangos-Petropulu, Neda Jahanshad, et al.
Nature Communications
|
March 4, 2024
Trans-lesion synthesis and mismatch repair pathway crosstalk defines chemoresistance and hypermutation mechanisms in glioblastoma
Xing Cheng, Jing An, Jitong Lou, et al.
Human Brain Mapping
|
May 29, 2020
Translating ENIGMA schizophrenia findings using the regional vulnerability index: Association with cognition, symptoms, and disease trajectory
Peter Kochunov, Fengmei Fan, Meghann C Ryan, et al.
JCI Insight
|
July 19, 2022
ARID1A-deficient bladder cancer is dependent on PI3K signaling and sensitive to EZH2 and PI3K inhibitors
Hasibur Rehman, Darshan S Chandrashekar, Chakravarthi Balabhadrapatruni, et al.
Blood
|
June 18, 2013
SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
May S Kung Sutherland, Roland B Walter, Scott C Jeffrey, et al.
Page
of 99